Daejeon, South Korea

Ho-Jun Kim

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Lg Life Sciences, Limited. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ho-Jun Kim. Retrieved from https://idiyas.com/inventor/ho-jun-kim-rbigsld1

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 27.0

ph-index = 1


Company Filing History:


Years Active: 2009

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ho-Jun Kim

Introduction

Ho-Jun Kim is a prominent inventor based in Daejeon, South Korea. He has made significant contributions to the field of biochemistry, particularly in the development of therapeutic agents. His work focuses on innovative solutions to combat inflammation and apoptosis.

Latest Patents

Ho-Jun Kim holds a patent for "Caspase inhibitors containing isoxazoline ring." This invention relates to an isoxazoline derivative that acts as an inhibitor against various caspases. The patent also details a process for preparing the isoxazoline derivative and a therapeutic composition that utilizes it to prevent inflammation and apoptosis. He has 1 patent to his name.

Career Highlights

Ho-Jun Kim is currently employed at LG Life Sciences, Limited, where he continues to advance his research and development efforts. His work at the company has positioned him as a key player in the field of pharmaceutical innovations.

Collaborations

Throughout his career, Ho-Jun Kim has collaborated with notable colleagues, including Hye-Kyung Chang and Yeong-Soo Oh. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Ho-Jun Kim's contributions to the field of biochemistry through his innovative patents and collaborations highlight his importance as an inventor. His work continues to pave the way for advancements in therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…